Segall Bryant & Hamill’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-135,909
| Closed | -$12M | – | 580 |
|
|
2025
Q1 | $12M | Sell |
135,909
-3,834
| -3% | -$339K | 0.18% | 174 |
|
|
2024
Q4 | $12.2M | Sell |
139,743
-1,879
| -1% | -$164K | 0.17% | 191 |
|
|
2024
Q3 | $13.1M | Buy |
141,622
+14,668
| +12% | +$1.36M | 0.18% | 185 |
|
|
2024
Q2 | $13.7M | Buy |
126,954
+3,457
| +3% | +$373K | 0.24% | 133 |
|
|
2024
Q1 | $11.7M | Sell |
123,497
-1,752
| -1% | -$166K | 0.22% | 160 |
|
|
2023
Q4 | $11.6M | Buy |
125,249
+30,099
| +32% | +$2.78M | 0.22% | 163 |
|
|
2023
Q3 | $4.78M | Sell |
95,150
-561
| -0.6% | -$28.2K | 0.06% | 328 |
|
|
2023
Q2 | $6.05M | Buy |
95,711
+531
| +0.6% | +$33.6K | 0.06% | 310 |
|
|
2023
Q1 | $4.28M | Sell |
95,180
-87,480
| -48% | -$3.94M | 0.05% | 359 |
|
|
2022
Q4 | $8M | Sell |
182,660
-25,971
| -12% | -$1.14M | 0.09% | 252 |
|
|
2022
Q3 | $13.7M | Buy |
208,631
+4,443
| +2% | +$293K | 0.16% | 160 |
|
|
2022
Q2 | $10.3M | Buy |
204,188
+28,752
| +16% | +$1.45M | 0.12% | 197 |
|
|
2022
Q1 | $11.2M | Buy |
175,436
+116,602
| +198% | +$7.45M | 0.11% | 202 |
|
|
2021
Q4 | $6.3M | Buy |
58,834
+15,498
| +36% | +$1.66M | 0.06% | 281 |
|
|
2021
Q3 | $4.45M | Buy |
43,336
+1,146
| +3% | +$118K | 0.04% | 354 |
|
|
2021
Q2 | $3.71M | Buy |
42,190
+2,557
| +6% | +$225K | 0.04% | 376 |
|
|
2021
Q1 | $3.85M | Sell |
39,633
-701
| -2% | -$68.1K | 0.04% | 380 |
|
|
2020
Q4 | $4.52M | Sell |
40,334
-749
| -2% | -$84K | 0.05% | 312 |
|
|
2020
Q3 | $3.81M | Buy |
41,083
+29,755
| +263% | +$2.76M | 0.05% | 295 |
|
|
2020
Q2 | $885K | Buy |
11,328
+340
| +3% | +$26.6K | 0.01% | 468 |
|
|
2020
Q1 | $642K | Sell |
10,988
-1,094
| -9% | -$63.9K | 0.01% | 536 |
|
|
2019
Q4 | $968K | Buy |
+12,082
| New | +$968K | 0.02% | 526 |
|